Skip to content
by Legal Desire
4 November 2025

Latham & Watkins Advises Arcus Biosciences in US$250 Million Public Offering of Common Stock

Advising firms

Deal team

15 lawyers named
LawyerFirmSeniorityPracticeOffice
Mark Roeder Lead Latham & Watkins LLP Partner corporate Bay Area
John Williams Lead Latham & Watkins LLP Partner corporate Bay Area
Caitlin Nguyen Latham & Watkins LLP Associate corporate Not stated
Eddie Magana Latham & Watkins LLP Associate corporate Not stated
Connor McCroskey Latham & Watkins LLP Not stated corporate Not stated
Christopher Hazuka Latham & Watkins LLP Partner intellectual property San Diego
Robert Yeh Latham & Watkins LLP Counsel intellectual property San Diego
Kristina Funahashi Latham & Watkins LLP Associate intellectual property Not stated
Elizabeth Richards Latham & Watkins LLP Partner regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner regulatory Bay Area
Chad Jennings Latham & Watkins LLP Counsel regulatory Washington, D.C.
Evan Miller Latham & Watkins LLP Associate regulatory Not stated
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Dennis Poehland Latham & Watkins LLP Associate tax Not stated
Jay Metz Latham & Watkins LLP Partner compensation and benefits Bay Area

12 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 250m (US$250 million)
What the figure measures
Issue size
Client
Arcus BiosciencesIssuer
Counterparties
Not stated